Wow!; ). Your so called futility rec ended up leading to publication in JAMA Oncology and submission to MHRA. Maybe more biotech companies should do what NWBO does so they can get peer reviewed by JAMA Oncology and get their submissions to regulators instead of having failed trials. Great point!; ). Best wishes.